Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexamethasone for prevention of postoperative sore throat
IRCT20180416039326N7Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of dexamethasone in Post-extubation sore throat (POST) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of sore throat, Severity of cough and 1 more. Started Jun 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20180416039326N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N7.